|
Researchers light up lungs to help diagnose disease
April 29, 2008Researchers at the University of Sheffield have developed innovative technology which illuminates a person's lungs and helps clinicians identify if they are functioning correctly. The new technology could result in earlier diagnosis of emphysema and smoking related damage, as well as other lung conditions and diseases.
Lung diseases are of growing concern to the health of the nation, with people suffering from conditions as mild as asthma or as severe as lung cancer. By detecting lung damage early, doctors could help slow down or stop the conditions.
The technique developed at Sheffield involves a person inhaling small amounts of harmless hyperpolarised (HP) noble gases (Helium-3 and Xenon-129), which are then imaged inside an MRI scanner. The gases are hyperpolarised using high power lasers by a process called optical pumping. The high resolution images of the airspaces that are produced offer additional functional information that is currently not available with traditional X-rays and lung CT scans.
The first clinical studies using this novel method have been carried out at the University of Sheffield, with the University holding the only UK regulatory licence to administer hyperpolarised gases for lung imaging.
Images obtained of lungs so far are shedding new light on a variety of different lung conditions and diseases. Tests carried out on smokers, for example, have shown signs of early emphysema.
The technology has also been used to help detect the early stages of lung obstruction in children with Cystic Fibrosis, something which a traditional X-ray would miss. The technique also allows repeated investigations in children without the fear of radiation exposure.
The researchers are also now looking at using the technology to assess inhaled therapies for asthma patients and help plan radiotherapy treatment in patients with lung cancer.
Jim Wild, a physicist from the University's Academic Unit of Radiology and the lead academic involved in the project, said: "The images produced are providing clinicians with functional information of the lungs that has previously been unattainable. The high sensitivity of the technology means that it offers real hope for detecting lung damage early.
"Being able to detect lung conditions and disease at an early stage could radically affect the lifespan and quality of life of patients. For children with cystic fibrosis it means that, with the right treatment, they could live longer. Patients who have successfully stopped smoking can also see how they can halt or slow down the damage being done to their lungs."
Notes for Editors: The research has been made possible with the support of major grants from the Engineering and Physical Science Research Council (EPSRC), the Department of Health and the European Union.
The University of Sheffield
The first clinical studies using this novel method have been carried out at the University of Sheffield, with the University holding the only UK regulatory licence to administer hyperpolarised gases for lung imaging.
Images obtained of lungs so far are shedding new light on a variety of different lung conditions and diseases. Tests carried out on smokers, for example, have shown signs of early emphysema.
The technology has also been used to help detect the early stages of lung obstruction in children with Cystic Fibrosis, something which a traditional X-ray would miss. The technique also allows repeated investigations in children without the fear of radiation exposure.
The researchers are also now looking at using the technology to assess inhaled therapies for asthma patients and help plan radiotherapy treatment in patients with lung cancer.
Jim Wild, a physicist from the University's Academic Unit of Radiology and the lead academic involved in the project, said: "The images produced are providing clinicians with functional information of the lungs that has previously been unattainable. The high sensitivity of the technology means that it offers real hope for detecting lung damage early.
"Being able to detect lung conditions and disease at an early stage could radically affect the lifespan and quality of life of patients. For children with cystic fibrosis it means that, with the right treatment, they could live longer. Patients who have successfully stopped smoking can also see how they can halt or slow down the damage being done to their lungs."
Notes for Editors: The research has been made possible with the support of major grants from the Engineering and Physical Science Research Council (EPSRC), the Department of Health and the European Union.
The University of Sheffield
Lung Condition News and Current Lung Condition Events RSSComputer game helps COPD patients breathe better
Patients with chronic obstructive pulmonary disease (COPD) may gain better control over their breathing and breathe more efficiently by using their breath to play a computer game, according to new research.
Treat all patients with rare lung disease to prevent stroke, say doctors
Treatment should be offered to all people with a particular rare lung condition, regardless of whether or not they show symptoms of it, say researchers and doctors behind a new study published today.
Preventing lung scarring may extend lives of lung cancer patients
Researchers have found that using a special type of drug called a pharmaceutical monoclonal antibody to block the integrin beta6-TGF-beta pathway prevents a serious side effect of radiation therapy for lung cancer patients - pulmonary fibrosis (scarring of the lungs), thereby extending patients' lives and improving their quality of life.
Steroids do not prolong survival in intensive care patients with ARDS on life support
Corticosteroids do not improve survival in patients with late-stage acute respiratory distress syndrome (ARDS), according to new results from the ARDS Clinical Research Network of the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health.
Assessment model gauges lung cancer risk based on medical history and genetics
Physicians have little to help them predict development of lung cancer in their patients-even a history of heavy smoking doesn't really help, since only a small fraction of lifetime smokers develops the cancer.
Two-drug treatment may block source of asthma and chronic bronchitis
Current treatments for asthma and chronic bronchitis aren't able to address the ultimate source of the problem-they can only alleviate symptoms.
Lung Damage From SARS Could Be From Immune Response To Infection
Results of a three-week follow-up study of 75 people with SARS from the Amoy Garden housing block in Hong Kong provide a new insight into the progression of severe acute respiratory syndrome (SARS). The study, fast-tracked for early publication, is published on THE LANCET'S website - www.thelancet.com A major outbreak of SARS involving 321 patients occurred in Amoy Garden, a high-rise housing estate in Hong Kong around March 24. Investigations suggested that the source of the outbreak was linked to a faulty sewage system, initially contaminated by the excreta of a person with SARS infection who visited the housing block. The first 75 adult patients, belonging to 57 households, were admitted
More Lung Condition News Articles
| © 2008 BrightSurf.com |